Homocysteine lowering and cardiovascular events after acute myocardial infarction.

PubWeight™: 9.53‹?› | Rank: Top 0.1%

🔗 View Article (PMID 16531614)

Published in N Engl J Med on March 12, 2006

Authors

Kaare Harald Bønaa1, Inger Njølstad, Per Magne Ueland, Henrik Schirmer, Aage Tverdal, Terje Steigen, Harald Wang, Jan Erik Nordrehaug, Egil Arnesen, Knut Rasmussen, NORVIT Trial Investigators

Author Affiliations

1: Institute of Community Medicine, University of Tromsø, Tromsø, Norway. kaare.bonaa@stolav.no

Associated clinical trials:

The Norwegian Vitamin Trial (NORVIT) | NCT00266487

NORVIT and WENBIT - Long-term Follow-up (NORVITWENBIT) | NCT00671346

5-Methyltetrahydrofolate Survival and Inflammation in ESRD Patients | NCT00626223

Articles citing this

(truncated to the top 100)

Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA (2008) 5.92

Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol (2006) 4.02

Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet (2006) 3.60

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ (2009) 2.46

Influence of nitrous oxide anesthesia, B-vitamins, and MTHFR gene polymorphisms on perioperative cardiac events: the vitamins in nitrous oxide (VINO) randomized trial. Anesthesiology (2013) 2.39

Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37

Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet (2011) 2.35

Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA (2008) 2.32

Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ (2013) 2.25

Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr (2009) 2.19

Homocysteine trials--clear outcomes for complex reasons. N Engl J Med (2006) 2.12

Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia. Blood (2011) 2.02

A multi-marker approach to predict incident CKD and microalbuminuria. J Am Soc Nephrol (2010) 1.95

Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ (2006) 1.93

Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ (2010) 1.89

Higher serum folate levels are associated with a lower risk of atopy and wheeze. J Allergy Clin Immunol (2009) 1.88

Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med (2009) 1.83

Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke (2010) 1.75

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ (2012) 1.63

Assessment and management of nutrition in older people and its importance to health. Clin Interv Aging (2010) 1.61

Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: an implication to coronary vasospasm. J Cell Physiol (2011) 1.54

Air pollution, smoking, and plasma homocysteine. Environ Health Perspect (2006) 1.53

The homocysteine paradox. Arterioscler Thromb Vasc Biol (2008) 1.50

Vitamin B12 and health. Can Fam Physician (2008) 1.44

The methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism. Am J Hum Genet (2007) 1.42

Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis (2010) 1.40

A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr (2008) 1.37

Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut (2006) 1.34

Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol (2008) 1.33

Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J (2008) 1.32

Traffic-related particles are associated with elevated homocysteine: the VA normative aging study. Am J Respir Crit Care Med (2008) 1.27

The treatment of hyperhomocysteinemia. Annu Rev Med (2009) 1.23

Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol (2010) 1.23

Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study. PLoS One (2014) 1.23

Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. Nutr Rev (2009) 1.21

Cancer risk with folic acid supplements: a systematic review and meta-analysis. BMJ Open (2012) 1.20

Limitations of observational evidence: implications for evidence-based dietary recommendations. Adv Nutr (2014) 1.19

Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice. Circ Res (2012) 1.18

Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev (2009) 1.17

Homocysteine imbalance: a pathological metabolic marker. Adv Nutr (2012) 1.14

Environmental exposures, epigenetics and cardiovascular disease. Curr Opin Clin Nutr Metab Care (2012) 1.12

Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study. Pharmacogenet Genomics (2008) 1.12

Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved. Endocr Relat Cancer (2013) 1.11

Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress. J Mol Cell Cardiol (2011) 1.11

Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance. PLoS One (2013) 1.10

Integrated stress response modulates cellular redox state via induction of cystathionine γ-lyase: cross-talk between integrated stress response and thiol metabolism. J Biol Chem (2012) 1.10

Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart (2006) 1.08

Hereditary thrombophilia. Thromb J (2006) 1.08

Vitamin B12 in health and disease. Nutrients (2010) 1.07

Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc. Cardiovasc Res (2011) 1.04

Quo vadis: whither homocysteine research? Cardiovasc Toxicol (2009) 1.04

Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. Am J Kidney Dis (2008) 1.03

Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia. JAMA Psychiatry (2013) 1.02

Too much folate: a risk factor for cancer and cardiovascular disease? Curr Opin Clin Nutr Metab Care (2009) 1.02

Micronutrients in health and disease. Postgrad Med J (2006) 1.01

Causality, mediation and time: a dynamic viewpoint. J R Stat Soc Ser A Stat Soc (2012) 1.00

Gender differences in cardiovascular disease: hormonal and biochemical influences. Reprod Sci (2010) 0.99

Homocysteine lowering and cardiovascular disease risk: lost in translation. Can J Cardiol (2007) 0.98

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials. J Inherit Metab Dis (2010) 0.98

Predictors of vitamin B6 and folate concentrations in older persons: the InCHIANTI study. Clin Chem (2006) 0.98

Parkinson disease and comorbid cerebrovascular disease. Nat Rev Neurol (2009) 0.97

Homocysteine, B vitamins, and cardiovascular disease. N Engl J Med (2006) 0.97

Homocysteine supplementation attenuates the unfolded protein response in a murine nutritional model of steatohepatitis. J Biol Chem (2009) 0.96

Oxidant stress in HIV-infected women from the Women's Interagency HIV Study. Antivir Ther (2009) 0.96

Should folic acid fortification be mandatory? No. BMJ (2007) 0.96

A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr (2008) 0.96

The annexin A2/S100A10 system in health and disease: emerging paradigms. J Biomed Biotechnol (2012) 0.96

Effect of L-methionine on hot flashes in postmenopausal women: a randomized controlled trial. Menopause (2009) 0.95

Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role? PPAR Res (2010) 0.94

Effects of L-isoleucine and L-valine on hot flushes and serum homocysteine: a randomized controlled trial. Obstet Gynecol (2008) 0.94

Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics (2011) 0.94

Relationship of homocysteine levels to quadriceps strength, gait speed, and late-life disability in older adults. J Gerontol A Biol Sci Med Sci (2007) 0.94

Diet and incident venous thromboembolism: the Iowa Women's Health Study. Am Heart J (2009) 0.94

Nutritional recommendations for cardiovascular disease prevention. Nutrients (2013) 0.94

Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat (2010) 0.94

Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost (2013) 0.92

Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice. Gastroenterology (2015) 0.92

Folic acid supplementation promotes mammary tumor progression in a rat model. PLoS One (2014) 0.92

Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. Circ Res (2009) 0.91

Association between low-dose folic acid supplementation and blood lipids concentrations in male and female subjects with atherosclerosis risk factors. Med Sci Monit (2013) 0.91

Results of observational studies: analysis of findings from the Nurses' Health Study. PLoS One (2014) 0.91

Defects in homocysteine metabolism: diversity among hyperhomocyst(e)inemias. Clin Chem Lab Med (2007) 0.91

Danshensu protects vascular endothelia in a rat model of hyperhomocysteinemia. Acta Pharmacol Sin (2010) 0.91

The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. BMC Cardiovasc Disord (2008) 0.90

Betaine and secondary events in an acute coronary syndrome cohort. PLoS One (2012) 0.90

Micronutrient intake in relation to all-cause mortality in a prospective Danish cohort. Food Nutr Res (2012) 0.89

NMDA receptor-mediated activation of NADPH oxidase and glomerulosclerosis in hyperhomocysteinemic rats. Antioxid Redox Signal (2010) 0.89

Effect of folic acid supplementation in pregnancy on preeclampsia: the folic acid clinical trial study. J Pregnancy (2013) 0.89

The ethics of testing a test: randomized trials of the health impact of diagnostic tests for infectious diseases. Clin Infect Dis (2012) 0.89

Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis. PLoS One (2011) 0.89

MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate. Am J Clin Nutr (2010) 0.88

Pre-operative homocysteine levels and morbidity and mortality following cardiac surgery. Eur Heart J (2009) 0.88

Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial. Am J Epidemiol (2010) 0.87

Plasma total cysteine and total homocysteine and risk of myocardial infarction in women: a prospective study. Am Heart J (2010) 0.87

Plasma homocysteine is elevated in COPD patients and is related to COPD severity. Int J Chron Obstruct Pulmon Dis (2007) 0.87

Vitamin B6 and colorectal cancer: current evidence and future directions. World J Gastroenterol (2013) 0.87

Role of homocysteine in aortic calcification and osteogenic cell differentiation. Atherosclerosis (2008) 0.87

A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial. FASEB J (2012) 0.86

Effect of folic acid and betaine supplementation on flow-mediated dilation: a randomized, controlled study in healthy volunteers. PLoS Clin Trials (2006) 0.86

Articles by these authors

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93

Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99

A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J (2013) 5.23

Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA (2008) 4.49

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet (2009) 4.11

Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability. PLoS Genet (2011) 3.56

Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet (2010) 3.34

Cohort profile: the Tromso Study. Int J Epidemiol (2011) 3.29

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96

Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83

Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA (2009) 2.66

[Diet changes and the rise and fall of cardiovascular disease mortality in Norway]. Tidsskr Nor Laegeforen (2004) 2.65

Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents. Am J Epidemiol (2008) 2.32

Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J (2005) 2.29

Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol (2011) 2.25

Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med (2006) 2.23

The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr (2006) 2.15

Echocardiographic screening of the general population and long-term survival: a randomized clinical study. JAMA Intern Med (2013) 2.13

Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromsø Study. Stroke (2011) 2.07

Impact of incident venous thromboembolism on risk of arterial thrombotic diseases. Circulation (2013) 2.04

Persistent postsurgical pain in a general population: prevalence and predictors in the Tromsø study. Pain (2012) 2.01

Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø Study. Stroke (2007) 1.93

[In Process Citation]. Tidsskr Nor Laegeforen (2016) 1.92

Body mass index in relation to adult asthma among 135,000 Norwegian men and women. Am J Epidemiol (2004) 1.88

Prevalence of cardiovascular diseases and associated risk factors in a rural black population of South Africa. Eur J Cardiovasc Prev Rehabil (2005) 1.81

Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls. Am J Epidemiol (2003) 1.79

Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet (2012) 1.77

Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology (2004) 1.73

Cohort profile: cohort of Norway (CONOR). Int J Epidemiol (2007) 1.72

Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem (2003) 1.70

Height and body mass index in relation to total mortality. Epidemiology (2003) 1.70

A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68

Thyroid stimulating hormone and left ventricular function. J Clin Endocrinol Metab (2007) 1.67

Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res (2002) 1.66

Self-reported smoking status and plasma cotinine concentrations among pregnant women in the Norwegian Mother and Child Cohort Study. Pediatr Res (2012) 1.65

Resting heart rate and physical activity as risk factors for lone atrial fibrillation: a prospective study of 309,540 men and women. Heart (2013) 1.61

Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001. Eur Heart J (2005) 1.61

Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat (2007) 1.59

Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis (2008) 1.59

Cobalamin status and its biochemical markers methylmalonic acid and homocysteine in different age groups from 4 days to 19 years. Clin Chem (2003) 1.58

Treatment outcome of new culture positive pulmonary tuberculosis in Norway. BMC Public Health (2005) 1.57

Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained. PLoS Genet (2013) 1.57

Cobalamin supplementation improves motor development and regurgitations in infants: results from a randomized intervention study. Am J Clin Nutr (2013) 1.53

Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry (2003) 1.50

A man's heart and a wife's education: a 12-year coronary heart disease mortality follow-up in Norwegian men. Int J Epidemiol (2002) 1.49

Can cardiovascular risk factors and lifestyle explain the educational inequalities in mortality from ischaemic heart disease and from other heart diseases? 26 year follow up of 50,000 Norwegian men and women. J Epidemiol Community Health (2004) 1.48

Ambulatory blood pressure is associated with measured glomerular filtration rate in the general middle-aged population. J Hypertens (2012) 1.48

Coffee consumption and circulating B-vitamins in healthy middle-aged men and women. Clin Chem (2008) 1.48

Seasonal variation in incidence of acute myocardial infarction in a sub-Arctic population: the Tromsø Study 1974-2004. Eur J Cardiovasc Prev Rehabil (2011) 1.45

Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Rep (2012) 1.45

Maternal folate levels in pregnancy and asthma in children at age 3 years. J Allergy Clin Immunol (2010) 1.44

Nonemergent coronary angioplasty without on-site surgical backup: a randomized study evaluating outcomes in low-risk patients. Am Heart J (2006) 1.44

Cardiovascular mortality in relation to birth weight of children and grandchildren in 500,000 Norwegian families. Eur Heart J (2012) 1.44

Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int (2010) 1.42

The SCORE risk model applied to recent population surveys in Norway compared to observed mortality in the general population. Eur J Cardiovasc Prev Rehabil (2006) 1.42

The methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism. Am J Hum Genet (2007) 1.42

Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.40

[Drug therapy]. Tidsskr Nor Laegeforen (2003) 1.40

Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr (2008) 1.37

Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant (2008) 1.30

Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardiovasc Prev Rehabil (2009) 1.28

DNA methylation as a long-term biomarker of exposure to tobacco smoke. Epidemiology (2013) 1.28

Food habits, physical activity and body mass index in relation to smoking status in 40-42 year old Norwegian women and men. Prev Med (2004) 1.27

Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry. Clin Chem (2005) 1.24

The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev (2007) 1.23

Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study. PLoS One (2012) 1.23

The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart (2012) 1.22

Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study. Osteoporos Int (2005) 1.22

Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC. Cancer Epidemiol Biomarkers Prev (2011) 1.21

Impaired fasting glucose is associated with renal hyperfiltration in the general population. Diabetes Care (2011) 1.20

Serum B vitamin levels and risk of lung cancer. JAMA (2010) 1.20

Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study. Eur J Endocrinol (2009) 1.19

Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study. J Bone Miner Res (2007) 1.18

Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur J Endocrinol (2010) 1.18

Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev (2010) 1.18

Body height and risk of venous thromboembolism: The Tromsø Study. Am J Epidemiol (2010) 1.18

Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study. Eur J Endocrinol (2004) 1.17

The sixth survey of the Tromso Study (Tromso 6) in 2007-08: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey. Scand J Public Health (2013) 1.16

Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev (2004) 1.15

Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromsø Study. Stroke (2005) 1.15